HSIC
HENRY SCHEIN INC
NASDAQ · Healthcare · Medical - Distribution · US
$84.96
−1.21%Year over year
Reported trailing growth
- Revenue
- +6.5%
- EBITDA
- +8.7%
- EBIT
- +0.0%
- EPS
- +10.2%
- Free cash flow
- +50.6%
- Operating cash flow
- +36.7%
Forward estimates
Based on analyst estimates
- Revenue
- +4.8%
- EBITDA
- +31.3%
- EPS
- +68.3%
Three-year CAGR
- Revenue
- +1.4%
- EBITDA
- +1.0%
- EBIT
- -6.9%
- Net income
- -9.6%
- EPS
- -5.9%
- Free cash flow
- +4.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026